A biotechnology company being acquired by Novartis.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Tourmaline Bio, Inc. in the last 30 days yet.
The 1 sources with the most insights about Tourmaline Bio, Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Set to be acquired by Novartis, which is a very bullish event for the stock of the company being acquired.
Set to be acquired by Novartis, which is a very bullish event for the stock of the company being acquired.
Other assets that creators frequently mention in the same content as Tourmaline Bio, Inc..
The most active sources covering Tourmaline Bio, Inc. (TRML) on Kazuha are Real Vision Podcast Network. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Tourmaline Bio, Inc. (TRML) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Tourmaline Bio, Inc. (TRML) most frequently also discuss XAU, HOOD, BTC, NGLOY, TECK. See the "Discussed alongside" section above for full asset pages.